Chipotle Mexican Grill, Inc. vs Twist Bioscience Corp — how do they compare? Chipotle Mexican Grill, Inc. trades at $32.66 (market cap $40.49B), while Twist Bioscience Corp trades at $122.96 (market cap $7.72B). The key difference: Chipotle Mexican Grill, Inc. is far larger — about 5.2× Twist Bioscience Corp's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Chipotle Mexican Grill, Inc. nearer its low. Which is the better fit depends on your goals.
| CMG | TWST | |
|---|---|---|
Market Cap | $40.49B | $7.72B |
Sector | Consumer Cyclical | Health |
52-Week High | $44.04 | $124.88 |
52-Week Low | $28.17 | $24.16 |
Enterprise Value | $45.24B | $7.65B |
Signals from Pluang's Aura AI — not financial advice
Chipotle Mexican Grill (CMG) trades at $32.615, up 1.48% today, but faces headwinds from recent food safety concerns linked to salmonella outbreaks. The stock's technical outlook is bearish, with moving averages signaling selling pressure. Fundamentally, the company reported strong revenue growth to $11.93B in 2025 and a net income margin of 11.42%, though earnings face compression from rising costs. Recent news highlights ongoing litigation investigations and promotional efforts to boost customer engagement.
The investment outlook is mixed; analyst consensus remains bullish with a $42.17 price target, but near-term risks from food safety issues and margin pressures could limit upside. Long-term growth prospects are supported by consistent revenue increases, but investors should monitor resolution of health concerns and cost management.
Twist Bioscience (TWST) trades at $125.13, up 0.2% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The company reported Q3 2026 revenue of $118.4 million, up 23% year-over-year, beating estimates, but posted a net loss. Revenue growth is strong, yet profitability remains elusive with negative margins. Recent news highlights an upsized $300 million public offering and expanding AI drug discovery pipeline.
Outlook is mixed: robust revenue growth and analyst optimism (78.57% buy ratings) support upside, but persistent losses, cash burn, and high valuation multiples pose significant risks. The stock's proximity to resistance at $126 suggests near-term volatility. Investors should weigh growth potential against financial sustainability concerns.
Trailing returns across standard periods
Latest headlines on both assets
Chipotle Mexican Grill is the largest fast-casual chain restaurant in the United States, with systemwide sales of $7.5 billion in 2021. The Mexican concept is entirely company-owned, with a footprint of more than 3,000 stores, heavily indexed to the United States (though the firm maintains a small presence in Canada, the U.K., France, and Germany). Chipotle sells burritos, burrito bowls, tacos, quesadillas, and beverages, with a selling proposition built around competitive prices, high-quality food sourcing, speed of service, and convenience. The company generates its revenue entirely from restaurant sales and delivery fees.
Read more on CMG →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →